Advertisement
War on cancer, take two

War on cancer, take two

By Maria Castellucci and Sabriya Rice  |  January 16, 2016

In light of the challenges seen since President Nixon launched the first "war on cancer" in 1971, experts say any new approach to cures, moonshot or otherwise, must get back to the basics. The oncology community agrees a coordinated approach could address the clinical research challenges.

Clinical pathways for cancer face fork in the road

By Sabriya Rice  |  January 16, 2016

Clinical pathways, lists meant to guide clinicians toward the optimal course of treatment, have reached the point of being an “unsustainable” administrative burden, according to the American Society of Clinical Oncology, and the process of developing them is laden with inadequacies and...

Pfizer-Allergan deal could reduce biosimilar cost savings

Pfizer-Allergan deal could reduce biosimilar cost savings

By Steven Ross Johnson  |  December 05, 2015

Pfizer's $160 billion deal to acquire Irish drugmaker Allergan got a lot of attention for the tax advantages Pfizer would enjoy from moving its New Jersey headquarters overseas to Dublin. There wasn't much talk, though, about how much the deal would expand Pfizer's footprint in biosimilars.

HealthWorks names Joseph Mallas CEO

HealthWorks names Joseph Mallas CEO

By Modern Healthcare  |  December 05, 2015

Joseph Mallas has been named president and CEO of U.S. HealthWorks, an occupational-health and urgent-care subsidiary of San Francisco-based Dignity Health.

CMS won't step in to provide stricter oversight of laboratory-developed tests

By Virgil Dickson  |  November 17, 2015

Providers say they don't have the resources to adhere to enforcement of decades-old laws calling for the FDA to police laboratory-developed tests. The CMS rejected requests that it, not the FDA, have oversight of the tests, which are manufactured and performed within a single hospital or in...

Elephants pack some cancer-fighting secrets

Elephants pack some cancer-fighting secrets

By Modern Healthcare  |  October 17, 2015

Cancer is much less common in elephants than in humans, even though the big beasts' bodies have many more cells. That's a paradox known among scientists, and now researchers think they may have an explanation.

Gold Award: Memorial Sloan Kettering Cancer Center

Gold Award: Memorial Sloan Kettering Cancer Center

By Andis Robeznieks  |  September 05, 2015

What particularly struck Design Awards judge Rulon Stacey about the new Memorial Sloan Kettering Cancer Center in West Harrison, N.Y., was the prominent staircase in the middle of the lobby.

Advertisement
Modern Healthcare Daily

Award winning coverage of healthcare business and policy news.

The Modern Healthcare app includes a personalized home screen, strong search functionality and immediate downloads from the industry's leading healthcare media brand.